Biosimilars naming, label transparency and authority of choice – survey findings among European physicians
Year: 2014
Type: article
Study design: Observational Study
Abstract: Introduction: A survey of the views of European physicians on familiarity of biosimilar medicines has demonstrated the need for distinguishable non-proprietary names to be given to all biologicals. Methods: The Alliance for Safe Biologic Medicines recruited 470 prescribers with clinical experience of biologicals in France, Germany, Italy, Spain and the UK to answer questions relating
Authors: Richard O Dolinar, Michael S Reilly
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W2047485232